Taking iron supplements every other day may help with absorption

20 Oct 2017 --- A study has found that in iron-depleted women, providing iron supplements daily as divided doses increases serum hepcidin and reduces iron absorption. According to the results, providing iron supplements on alternate days and in single doses optimizes iron absorption and might be a preferable dosing regimen.

The study, published in The Lancet Haemotology and funded by the Swiss National Science Foundation, made sure supplements were given on consecutive versus alternate days and given as single morning doses versus twice-daily split dosing.

Current guidelines to treat iron deficiency recommend daily provision of ferrous iron divided through the day to increase absorption. However, there was an idea that daily dosing and split dosing might increase serum hepcidin and decrease iron absorption from subsequent doses. The researchers note that their study aim was to compare iron absorption from oral iron supplements given on consecutive versus alternate days and given as single morning doses versus twice-daily split dosing.

Testing different doses
The researchers did two prospective, open-label, randomized controlled trials assessing iron absorption using (54Fe)-labelled, (57Fe)-labelled or (58Fe)-labelled ferrous sulfate in iron-depleted women aged 18 to 40 years recruited from ETH Zurich and the University of Zurich, Switzerland.

In study 1, women were randomly assigned to two groups. One group was given 60 mg iron at 8am on consecutive days for 14 days, and the other group was given the same doses on alternate days for 28 days. In study 2, women were assigned to two groups, stratified by serum ferritin so that two groups with similar iron statuses could be formed. One group was given 120 mg iron at 8am and the other was given the dose split into two divided doses of 60 mg at 8am and 5pm for three consecutive days.

Eventually, 14 days after the final dose, the groups were each crossed over to the other regimen. Within-individual comparisons were done. The co-primary outcomes in both studies were iron bioavailability (total and fractional iron absorption), assessed by measuring the isotopic label abundance in erythrocytes 14 days after administration, and serum hepcidin. Group allocations in both studies were not masked and primary and safety analyses were done on an intention-to-treat basis.

Results find significant difference
For study 1, 40 women were enrolled on October 15 to 29, 2015. In addition, 21 women were assigned to the consecutive-day group and 19 to the alternate-day group. At the end of treatment (14 days for the consecutive-day group and 28 days for the alternate-day group), geometric mean cumulative fractional iron absorptions were 16.3 percent in the consecutive-day group versus 21.8 percent in the alternate-day group, and cumulative total iron absorption was 131.0mg versus 175.3mg. During the first 14 days of supplementation in both groups, serum hepcidin was higher in the consecutive-day group than the alternate-day group.

In study 2, 20 women were enrolled between Aug 13 and 18, 2015. Ten women were assigned to receive once-daily dosing and ten were assigned to receive twice-daily divided dosing. No significant differences were seen in fractional (day 1-3 geometric mean: 11·8 percent once daily versus 13.1 percent twice daily) or total iron absorption (day 1-3: 44.3mg once daily versus 49·4mg twice daily) between the two dosing regimens. Twice-daily divided doses resulted in a higher serum hepcidin concentration than once-daily dosing. No grade 3 or 4 adverse events were reported in either study.

“Providing iron supplements on alternate days and in single doses optimises iron absorption and might be a preferable dosing regimen,” the researchers conclude. “These findings should be confirmed in iron-deficient anemic patients.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Microbiome solutions: A key theme at Vitafoods Europe 2018

24 May 2018 --- Research into the microbiome – the aggregated microbial species in our body – is gaining increasing attention and investment. Although the term is often associated with digestive health, the body, in fact, contains multiple microbiome. This is currently spurring on research and innovation in areas as wide-ranging as women’s health, weight management, immunity and skin health. At Vitafoods Europe 2018, NutritionInsight spoke with suppliers about their efforts and innovations in the microbiome space, using pre or probiotics for gut health and beyond.

Nutrition & Health News

Nutrient breakthrough: Scientists show plants can be a dietary source of vitamin B12

24 May 2018 --- Scientists at the University of Kent have made a significant discovery about how the vitamin B12 content of some plants can be improved to make vegetarian and vegan diets more complete. Vitamin B12 (known as cobalamin) is an essential dietary component but vegans and vegetarians are more prone to B12 deficiency as plants neither make nor require this nutrient.

Nutrition & Health News

A personal nutrition touch: A key theme at Vitafoods Europe 2018 

22 May 2018 --- Personalized nutrition has become somewhat of a buzzword in the industry over the past year. But despite its popularity, the term “personalized nutrition” is open to many different interpretations, raising the question of how it is actually to be applied in the industry, with experts pointing to the role of wearable devices, mobile apps and forward-looking options such as genetic profiling. At Vitafoods Europe, NutritionInsight spoke with a number of suppliers about their R&D and views on personalized nutrition.    

Nutrition & Health News

Marealis’ novel shrimp peptide gains EFSA green light

22 May 2018 --- The European Food Safety Authority (EFSA) has approved an application for the novel food status of a shrimp peptide concentrate, meaning that the ingredient can now be utilized in EU supplement applications. The application was made by the company Medfiles Ltd. on behalf of Marealis, a developer of science-backed nutraceuticals. The supplements will be marketed to those who want to address the problem of prehypertension in the Marealis product, PreCardix.

Nutrition & Health News

Targeting aching joints: A key theme at Vitafoods Europe 2018

21 May 2018 --- World populations are getting older and with age, the risk of bone and joint health issues – such as rheumatoid arthritis and osteoarthritis – increases. Moreover, joint health concerns also affect younger consumers, such as so-called “weekend warriors,” who exercise once or twice a week, meaning that the joint health market is of interest not just to senior citizens but also to any consumers seeking to live an active life. Among the different innovative healthy aging and lifestyle solutions presented at Vitafoods Europe this year, there was a clear spot for ingredients aimed at supporting joint health.

More Articles
URL : http://www.nutritioninsight.com:80/news/taking-iron-supplements-every-other-day-may-help-with-absorption.html